Innoviva, Inc. Uncategorized Contracts & Agreements

33 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Innoviva, Inc. Employment Offer Letter Agreement with Stephen Basso (Chief Financial Officer)
Employment Agreements
Innoviva, Inc.
Pharmaceuticals
DE
2023
Support Agreement among Innoviva, Inc., Innoviva Acquisition Sub, Inc., and Stockholders of La Jolla Pharmaceutical Company
Voting Agreements
Innoviva, Inc.
Pharmaceuticals
2022
Innoviva, Inc. Employment Offer Letter Agreement with Pavel Raifeld dated April 29, 2022
Employment Agreements
Innoviva, Inc.
Pharmaceuticals
2022
Letter Agreement Regarding Distribution and Capital Contribution between ISP Fund LP, Sarissa Capital Fund GP LP, and Innoviva Strategic Partners LLC (May 20, 2021)
Distribution Agreements
Innoviva, Inc.
Pharmaceuticals
2021
Innoviva, Inc. Employment Offer Letter Agreement with Pavel Raifeld
Employment Agreements
Innoviva, Inc.
Pharmaceuticals
2020
Description of Innoviva, Inc. Common Stock Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Innoviva, Inc.
Pharmaceuticals
2020
Innoviva, Inc. Chief Accounting Officer Promotion and Compensation Letter Agreement with Marianne Zhen
Employment Agreements
Innoviva, Inc.
Pharmaceuticals
2018
Innoviva, Inc. Employment Offer Letter to Geoffrey L. Hulme (Interim Principal Executive Officer)
Employment Agreements
Innoviva, Inc.
Pharmaceuticals
CA
2018
Agreement Regarding Board Composition and 2018 Annual Meeting between Innoviva, Inc. and Sarissa Group
Voting Agreements
Innoviva, Inc.
Pharmaceuticals
DE
2018
Innoviva, Inc. Interim Principal Executive Officer Employment Offer Letter with Eric d'Esparbes (February 2018)
Employment Agreements
Innoviva, Inc.
Pharmaceuticals
2018
Theravance, Inc. Employment Offer Letter to Michael E. Faerm (Senior Vice President, Chief Business Officer)
Employment Agreements
Innoviva, Inc.
Pharmaceuticals
2016
Theravance, Inc. Employment Offer Letter to Eric d'Esparbes for Senior Vice President and CFO Position
Employment Agreements
Innoviva, Inc.
Pharmaceuticals
2015
Theravance Equity Award Adjustment Agreement for VP-Level Employees in Connection with Spin-Off
Compensation Agreements
Innoviva, Inc.
Pharmaceuticals
2014
Employee Matters Agreement between Theravance, Inc. and Theravance Biopharma, Inc. (June 1, 2014)
Separation Agreements
Innoviva, Inc.
Pharmaceuticals
DE
2014
Annex A: Rules of Construction and Defined Terms for Transaction Documents
Modification Agreements
Innoviva, Inc.
Pharmaceuticals
DE
2014
Account Control Agreement among LABA Royalty Sub LLC, Theravance, Inc., and U.S. Bank National Association (April 17, 2014)
Escrow Agreements
Innoviva, Inc.
Pharmaceuticals
NY
2014
Amendment to Strategic Alliance Agreement between Theravance, Inc. and Glaxo Group Limited (GSK) – March 3, 2014
Modification Agreements
Innoviva, Inc.
Pharmaceuticals
DE
2014
Master Agreement among Theravance, Inc., Theravance Biopharma, Inc., and Glaxo Group Limited (GSK) Regarding Spin-Off and Related Consents
Collaboration Agreements
Innoviva, Inc.
Pharmaceuticals
DE
2014
Commercialization Agreement between Theravance, Inc. and Clinigen Group PLC (Telavancin/VIBATIV®)
Collaboration Agreements
Innoviva, Inc.
Pharmaceuticals
NY
2013
Theravance, Inc. Amendment to Non-Employee Director Restricted Stock Unit Awards (December 2010)
Modification Agreements
Innoviva, Inc.
Pharmaceuticals
2011
Theravance, Inc. Amended Cash Bonus Program Effective February 10, 2010
Bonus & Incentive Agreements
Innoviva, Inc.
Pharmaceuticals
2010
Theravance, Inc. 2008 New Employee Equity Incentive Plan (as Amended July 21, 2009)
Equity Distribution Agreements
Innoviva, Inc.
Pharmaceuticals
2009
Consulting Agreement between Arthur Campbell and Theravance, Inc. Effective December 6, 2008
Consulting Agreements
Innoviva, Inc.
Pharmaceuticals
CA
2008
Amendment to Amended and Restated Rights Agreement between Theravance, Inc. and The Bank of New York Mellon Corporation
Modification Agreements
Innoviva, Inc.
Pharmaceuticals
2008
Consulting Agreement between Michael M. Kitt, M.D. and Theravance, Inc. (Effective June 22, 2008)
Consulting Agreements
Innoviva, Inc.
Pharmaceuticals
CA
2008
Theravance, Inc. 2004 Equity Incentive Plan Nonstatutory Stock Option Grant Agreement
Stock Agreements
Innoviva, Inc.
Pharmaceuticals
DE
2007
Theravance, Inc. Amended Cash Bonus Program Effective February 28, 2007
Bonus & Incentive Agreements
Innoviva, Inc.
Pharmaceuticals
2007
Theravance, Inc. Common Stock Certificate
Stock Agreements
Innoviva, Inc.
Pharmaceuticals
2007
Amendment to License, Development and Commercialization Agreement between Theravance, Inc. and Astellas Pharma Inc.
License Agreements
Innoviva, Inc.
Pharmaceuticals
2006
Base Capped Call Option Confirmation between Innoviva, Inc. and [Dealer Name] dated March 2, 2022
Innoviva, Inc.
Pharmaceuticals
2022
Tax Matters Agreement between Theravance, Inc. and Theravance Biopharma, Inc. dated June 2, 2014
Innoviva, Inc.
Pharmaceuticals
DE
2014
First Addendum to Terms & Conditions Agreement between Theravance, Inc. and Ben Venue Laboratories, Inc. (Manufacture of TD-6424)
Innoviva, Inc.
Pharmaceuticals
OH
2007
Consulting Agreement between Marty Glick and Theravance, Inc. (Effective July 15, 2005)
Consulting Agreements
Innoviva, Inc.
Pharmaceuticals
CA
2005